Zymeworks (ZYME) Short-term Investments (2021 - 2026)
Zymeworks recorded quarterly Short-term Investments of $120.4 million in Q1 2026, down 35.81% quarter-over-quarter from $187.6 million in Q4 2025, and down 36.3% year-over-year from $189.1 million in Q1 2025.
Zymeworks' Short-term Investments history runs 6 years deep, the most recent figure standing at $120.4 million for Q1 2026.
- In Q1 2026, Short-term Investments fell 36.3% year-over-year to $120.4 million; the TTM figure through Mar 2026 stood at $120.4 million (down 36.3% YoY), while the FY2025 annual figure was $187.6 million, up 17.52% from the prior year.
- Short-term Investments came in at $120.4 million for Q1 2026 at Zymeworks, down from $187.6 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $259.2 million in Q2 2024 to a low of $70.2 million in Q3 2022.
- A 5-year average of $175.2 million and a median of $187.1 million in 2025 frame the typical range for Short-term Investments.
- Across the five-year window, Short-term Investments surged 186.59% in 2023 and sank 36.3% in 2026, its largest moves.
- Zymeworks' Short-term Investments stood at $91.3 million in 2022, then jumped by 137.37% to $216.8 million in 2023, then slipped by 26.34% to $159.7 million in 2024, then grew by 17.52% to $187.6 million in 2025, then tumbled by 35.81% to $120.4 million in 2026.
- According to Business Quant data, Short-term Investments over the past three periods registered $120.4 million, $187.6 million, and $187.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 120.45 Mn |
| Dec 31, 2025 | 187.64 Mn |
| Sep 30, 2025 | 187.10 Mn |
| Jun 30, 2025 | 183.13 Mn |
| Mar 31, 2025 | 189.08 Mn |
| Dec 31, 2024 | 159.67 Mn |
| Sep 30, 2024 | 174.84 Mn |
| Jun 30, 2024 | 259.18 Mn |
| Mar 31, 2024 | 230.23 Mn |
| Dec 31, 2023 | 216.77 Mn |
| Sep 30, 2023 | 201.07 Mn |
| Jun 30, 2023 | 197.99 Mn |
| Mar 31, 2023 | 159.21 Mn |
| Dec 31, 2022 | 91.32 Mn |
| Sep 30, 2022 | 70.16 Mn |
| Dec 31, 2021 | 50.74 Mn |